drugset / Trial / NCT00003042

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

NCT00003042

Non-randomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: This phase II trial is studying how well chemotherapy and stem cell transplantation work in treating patients with stage IIIB breast cancer.

Timeline

Start
1997-05-30
Primary completion
2010-02-09
Completion
2025-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Doxorubicin Other / unclassified Intravenous
Subject Melphalan Small molecule
Subject Paclitaxel Small molecule Intravenous
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule
Background Tamoxifen Small molecule
Background filgrastim Protein / enzyme biologic Intravenous

Indications